Type 2 diabetes mellitus patients were on the following diabetic medications: oral hypoglycemic drugs (83.1%), oral hypoglycemic drugs and insulin (13.5%), and dietary management (3.5%). The gene discussed is INS; the disease is type 2 diabetes mellitus.